Multiple Myeloma: International Myeloma Foundation : ASH 2011: Dr. Adel - Cost Analysis of Using Plerixafor Plus G-CSF Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma Patients Treated At Memorial Sloan-Kettering Cancer Center (MSKCC)

back

ASH 2011: Dr. Adel - Cost Analysis of Using Plerixafor Plus G-CSF Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma Patients Treated At Memorial Sloan-Kettering Cancer Center (MSKCC)

Nelly G. Adel, PharmD, BCOP, BCPS
Memorial Sloan-Kettering Cancer Center
New York, New York, USA

	12.01.11
Be the first to comment Name Email Address URL Remember personal info? Comments (You may use HTML tags for style)	print share \| related articles

Be the first to comment